The American Sheep Industry Association (ASI) joined a community of livestock producers, companion animal care providers, veterinarians and medicine manufacturers to encourage timely reauthorization of the Animal Drug User Fee Act (ADUFA).
ADUFA is in its third generation of the program and authorizes the Food and Drug Administration to collect fees from animal health companies to enable the Center for Veterinary Medicine to meet performance standards. ADUFA has been critical in streamlining the regulatory process to get much needed products to market.
An effective and efficient animal drug approval process is essential, both to the health and well-being of animals and to overall public health. The long-recognized threats of zoonotic diseases, such as food borne bacteria that can cause illness in people, demonstrate that the need to protect public health by protecting animal health has never been more important. An efficient review process allows for the availability of new and innovative products to meet these challenges. It also encourages animal health companies to continue investing in the research and development of new products. Those investments, spread across research facilities in over 40 states, totaled approximately $690 million in 2010.